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C(sp2)–H functionalization in non-aromatic
azomethine-based heterocycles
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Valery N. Charushin,a,b Oleg N. Chupakhin *a,b and Bert U. W. Maes *c
Direct C(sp2)–H functionalization of the endocyclic azomethine and aldonitrone moieties in non-aromatic aza-
heterocycles has established itself as a promising methodology over the last decade. Transition metal-catalyzed
cross-coupling reactions, α-metalation–electrophile quenching protocols, and (metal-free) nucleophilic substi-
tution of hydrogen reactions (SN
H) are the major routes applied on cyclic imines and their derivatives. In this over-
view, we show the tangible progress made in this area during the period from 2008 to 2020.
1. Introduction
Nitrogen-containing heterocycles certainly belong to one of the
most important classes of organic compounds, and their sig-
nificance for the existence of any living system can hardly be
overestimated. The accumulation of knowledge on these struc-
tures, which are widely spread in nature, has enhanced the
progress in organic chemistry, as well as in other scientific
fields, particularly in biomolecular chemistry, biology, medic-
inal chemistry, and materials science.1 Over the past century, a
large number of synthetic methods to modify azaheterocyclic
scaffolds have been elaborated, allowing one to obtain novel,
often quite complicated molecules, useful for the direct syn-
thesis of fine chemicals (e.g., pharmaceuticals or agrochem-
icals), dyes, and other industrially important compounds.2
Moreover, since the earliest stage of heterocyclic chemistry,
azaaromatic compounds have been considered as very attrac-
tive structural motifs, based on their versatile practical appli-
cations. The synthesis of these compounds is generally rea-
lized through lengthy multi-step approaches.3 With the
increasing awareness and importance of green chemistry,4 che-
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mists need to develop alternative efficient synthetic sequences
towards azaheterocyclic compounds in accordance with the
principles of green chemistry encompassing the pot, atom,
and step-economical (PASE) philosophy.5 In particular, the
direct functionalization of C(sp2)–H bonds has gained signifi-
cant interest of the scientific community as a general approach
to construct C–C bonds between two pre-designed structural
units.6 Such a methodology has the potential to perform better
with respect to the principles of green chemistry in compari-
son to the very powerful classical cross-coupling reactions,
which revolutionized the fine chemicals and specialty chemi-
cals synthesis at both discovery and development levels.7
However, regioselectivity problems, directing groups, and
requirements of specific [(super)stoichiometric] additives or
solvents can hamper its green potential, so a holistic green
metrics analysis objectively comparing the different processes,
i.e. direct C(sp2)–H bond functionalization versus cross-coup-
ling, will always be required for every specific case.4,8 This does
not only involve the C–C bond forming reaction itself, but also
how the reactants are synthesized.
The progress in exploiting this methodology for the direct
C(sp2)–H functionalization of non-aromatic azaheterocycles
proved to be not so straightforward and well-studied in com-
parison with the field of (hetero)aromatic chemistry. However,
in the last decade, significant headway in C(sp2)–H functionali-
zation of non-aromatic azaheterocycles has been made.
Interestingly, most compounds in those studies contain an
endocyclic azomethine (i.e. –CvN–) moiety. Cyclic azomethine
derivatives of both natural and synthetic origin are known to
exhibit profound biological activities or other practically useful
properties.9–13 For instance, the cyclic aldimine nectrisine
(Fig. 1a) isolated from the fungus Nectria lucida was found to
induce the expression of antigen Ia, thus enabling the restor-
ation of the immune response depressed by immunosuppres-
sive factors of tumors. Nectrisine could also be used for the
treatment of type 2 diabetes, since it exhibits α-glucosidase
inhibitory activity.9 Koranimine (Fig. 1b), another natural
product with a cyclic imine moiety, belongs to the family of
peptides obtained by non-ribosomal biosynthesis. Compounds
of this type are likely to exhibit a wide spectrum of biological
activities ranging from antibiotic to antitumor effects.10
Besides that, a number of cycloimines of natural origin are
known for their fast-acting toxic effects; the latter include spir-
ocyclic compounds secreted by marine shellfish, (e.g., gymno-
dimine A, Fig. 1c).11
As for compounds obtained synthetically, one has to high-
light the family of psychoactive benzodiazepines used
broadly in medicinal practice for the treatment of anxiety
disorders, epilepsy, insomnia, and withdrawal syndrome
(Fig. 1d shows diazepam, one of the most famous benzo-
diazepine tranquilizers). Another class of compounds that
deserves special attention is the cyclic nitrones, many of
which proved to be effective spin traps, used for detection
and identification of free radicals,12 and also potential thera-
peutic agents, particularly nitric oxide donors.13 A classic
example of a cyclic nitrone is 5,5-dimethylpyrroline N-oxide
(DMPO, Fig. 1e).
Taking into account the versatile applications of cyclic
imine derivatives, there is no doubt that the development of
efficient synthetic approaches towards such compounds is of
importance for modern organic chemistry. In this overview, we
discuss in detail the novel approaches based on C(sp2)–H
bond functionalization in non-aromatic azomethine-contain-
ing azaheterocycles that have been developed over the last
decade. The reported methods can be classified into three
general categories:
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• transition metal-catalyzed C(sp2)–H bond functionali-
zation of azomethine moieties;
• C(sp2)–H metalation of azomethine moieties (followed
by treatment with electrophiles);
• nucleophilic substitution of hydrogen (SN
H) at the sp2-
carbon in azomethine moieties.
We should note that this survey does not embrace the
C(sp2)–H activation in planar azomethine-based heterocycles,
containing an aromatic resonance structure or aromatic tauto-
mer, which can at least partly be regarded as aromatic ones
(e.g., quinoxalin-2(1H)-ones, quinazolin-4(3H)-ones, pyrazin-2
(1H)-ones, etc.). The vigorously developing chemistry of some
of these valuable compounds has recently been highlighted in
other review articles,14 and it keeps updating dynamically with
new functionalization examples.15
1.1. Transition metal-catalyzed C(sp2)–H bond functionali-
zation of azomethine moieties
The discovery of transition metal-catalyzed C–C bond forming
cross-coupling reactions in the sixties and seventies has had a
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Fig. 1 Selected examples of cyclic azomethine derivatives of specific interest for their application.
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large impact on the disconnections currently made in organic
synthesis. The outstanding achievements of R. Heck, A.
Suzuki, E. Negishi, J. Stille, K. Sonogashira, and other distin-
guished scientists have contributed greatly to the progress in
the chemistry of the functionalization of (hetero)aromatics.16
The first results in the ‘conventional’ cross-coupling chemistry
involving AG-substituted cyclic azomethines (AG = halogen,
SnAlk3, or other auxiliary groups) were reported in the early
1980s,17 whereas the analogous metal-catalyzed transform-
ations exploiting the reactivity of the endocyclic azomethine
C(sp2)–H bond remained unexplored until the late 2000s
(vide infra).18 Notably, the C–H functionalization methodology
can be realized here in two modes.
The first approach involves a new carbon–carbon bond for-
mation through the reaction of the imine C(sp2)–H with a
(pseudo)halogenated coupling partner (Scheme 1a), while the
second one encompasses the formation of a new bond via
double C–H bond activation. The latter is also known as cross-
dehydrogenative coupling (CDC), requiring an oxidant to
obtain a catalytic process (Scheme 1b).19
1.2. C(sp2)–H metalation of azomethine moieties
The inherent insufficient nucleophilicity of the carbon center
prevents direct C–H functionalization of azomethine (R–
NvCH–R′) moieties via electrophilic agents. Therefore, C–C
coupling reactions can only be performed by activating the
azomethine C(sp2)–H bond first via metalation through depro-
tonation, e.g., using organolithium or organomagnesium
reagents,20 followed by treatment with electrophiles
(Scheme 2). The pioneering research studies in the field of
electrophilic transformations of cyclic azomethine derivatives
were carried out by Voinov & Grigor’ev et al. in the late 1990s.21
They succeeded in developing α-lithiation of cyclic aldoni-
trones 3 and 7a generating the corresponding lithium salts
(e.g., 3-Li), which were reacted with electrophilic reactants,
such as aldonitrones 3 as well as ketones/aldehydes 5
(Scheme 3).
1.3. Nucleophilic substitution of hydrogen (SN
H) in azo-
methine moieties
Nucleophilic substitution of hydrogen (SN
H) has proved to
be an efficient synthetic tool to modify (hetero)aromatic
compounds with nucleophilic reactants since the seventies,
and it was successfully exploited during the next four
decades by many researchers.6a,22 Although a few scattered
examples employing this strategy for non-aromatic unsatu-
rated heterocycles date back to the early eighties,23 the
majority of such SN
H reactions have only been reported in
the 21st century.
A cyclic aldimine derivative is polarized and contains a
partial positive charge at the sp2-hybridized carbon, and this
center is therefore vulnerable to reaction with nucleophiles
(Scheme 4). Nucleophilic substitution of hydrogen proceeds
either via an ‘Addition–Elimination’ (SN
H(AE), Scheme 4a) or
an ‘Addition–Oxidation’ mechanism (SN
H(AO), Scheme 4b).22h
Scheme 1 Two possible modes for the TM-catalyzed C(sp2)–H bond
functionalization of azomethines.
Scheme 2 Metalation of the C(sp2)–H bond of a cyclic azomethine
derivative (i.e. nitrone 1) followed by electrophilic substitution.
Scheme 3 Selected examples of the coupling reaction of α-lithiated
aldonitrones with electrophilic reactants.
Review Organic & Biomolecular Chemistry


























































































They both start with the addition of a nucleophilic reactant
(Nu−) to the azomethine carbon of 11 to form an anionic σH-
adduct 12. According to an SN
H(AE) mechanism, subsequent
spontaneous or externally-promoted elimination of the leaving
group regenerates the azomethine π-bond. Selection of the
elimination promoters determines the specific features of the
SN
H reaction used. On the other hand, via an oxidizing
reagent, the equilibrium can also be shifted in favor of the SN
H
product 14, i.e. the oxidative SN
H(AO) mechanism.
Functionalization of azomethine derivatives involving an
SN
H(AE) pathway was not reported until the last decade.24
Notably, this ‘Addition–Elimination’ strategy has been fre-
quently applied for the modification of (hetero)aromatic sub-
strates, but not for saturated systems.22c In contrast, the
alternative oxidative SN
H(AO) protocols are well documented
here, as illustrated by transformations of aldonitrones 15, 16a–
b (Scheme 5).25 Transition metal oxides derived from manga-
nese (Scheme 5b and c), nickel (Scheme 5a), lead,23a and mer-
cury23b are commonly used as oxidizing agents. Oxidations
employing air23c or hydrogen peroxide,25a supplemented with
catalytic additives, which are more sustainable,26 were also
exploited.
2. C(sp2)–H functionalization in
cyclic aldimines and related
compounds
The first report describing the direct arylation of a cyclic imine
was published in 2008.18 A research team from the University
of California (Berkeley) introduced a phenyl moiety at the
2-position of 4,4-dimethyloxazoline (17a), a non-aromatic com-
pound (Scheme 6), in the presence of a rhodium source and
Scheme 4 ‘Addition–Elimination’ (a) and ‘Addition–Oxidation’ (b) mechanisms for the nucleophilic substitution of hydrogen (SN
H).
Scheme 5 Selected examples of SN
H(AO) reactions on cyclic azomethines.
Scheme 6 RhI-Catalyzed C(sp2)–H arylation of 4,4-dimethyloxazoline
(17a).
Organic & Biomolecular Chemistry Review


























































































(Z)-1-tert-butyl-2,3,6,7-tetrahydrophosphepine (20) as a ligand.
The catalytic cycle proposed by the authors (Scheme 7) involves
the initial formation of dimeric complex 21 from dimeric
[RhCl(coe)2]2 and bidentate phosphepine ligand 20.
Dissociation of this complex and coordination with the
imidate nitrogen of 4,4-dimethyloxazoline (17a) are likely to
promote the formation of intermediate 22 in a similar manner
as described for heteroaromatic substrates with rhodium com-
plexes, such as RhCl(PCy3)2.
27 A low-valent electron-rich
carbene-rhodium complex 23 is then generated via a C–H acti-
vation/tautomerization process.27 Subsequent oxidative
addition with phenyl bromide 18a delivers a (phenyl)(carbene)
rhodium complex 24. Elimination of HBr could then either
occur via the amine base or via an intramolecular process,
affording intermediate 25. Finally, reductive elimination
results in the formation of 19a and regeneration of the
rhodium catalyst.
In 2011, the Ackermann group reported a similar C(sp2)–H
arylation of oxazolines 17 involving Pd rather than Rh catalysis
(Scheme 8).28 A palladium complex 26 formed from Pd(OAc)2
and secondary phosphine oxide ‘pre-ligands’ were found to be
suitable (Scheme 9). A series of arylated oxazolines (19) were
successfully obtained, varying substituents in both the aryl
and oxazoline moieties.
Another report on the successful C(sp2)–H arylation of non-
aromatic heterocycles was published by the Ellman group.29
Herein, benzotriazepinones 29, which can be considered as
cyclic hydrazones, were subjected to Cu-catalyzed C–H
functionalization with a range of aryl iodides (30, Scheme 10).
Being close analogues of pharmaceutically privileged benzo-
diazepines, these azaheterocyclic derivatives are of interest as
biologically active substances. The reaction conditions were
initially similar to those proposed by Daugulis for the arylation
of aromatic C–H bonds (polyfluoroarene or heteroaromatic)
with aryl iodides and bromides.30 However, under those con-
ditions, arylated benzotriazepinone 31c was only obtained in
40% yield. To reach sufficient conversion, a longer reaction
time (12 h) was required than that initially reported
(10–30 min). Further optimization of the reactant ratio (29 : 30)
afforded a range of 5-aryl-substituted benzotriazepinones 31 in
rather good yields (Scheme 10).
Palladium in combination with copper catalysis was
explored by the scientists from the University of Rouen
(France). In 2015, they reported the direct arylation and olefi-
nation of imidazolones 32 (Scheme 11).31 Heterocycles of this
class are present in nature and exhibit therapeutic and fluo-
rescence properties.31 Aryl or alkenyl halides (33 and 35) were
used as coupling partners with 1,8-diazabicyclo[5.4.0]undec-7-
ene (DBU) as a base. It is noteworthy that such arylations and
olefinations required different solvents (DMF or toluene) and
phosphine ligands (PPh3 or P(o-Tol)3) to obtain appropriate
yields of products (34 and 36, see Scheme 11). The potential of
this strategy was illustrated for the synthesis of imidazolone-
containing fatty acid synthase (FAS) inhibitors.31 This group
also extended this approach for the C(sp2)–H functionalization
of 4-arylidene imidazolones, enabling a library of GFP and
Kaede protein-type fluorophores.32
Scheme 7 Proposed mechanism for the RhI-catalyzed C(sp2)–H aryla-
tion of 4,4-dimethyloxazoline (17a).
Scheme 8 Pd-Catalyzed C(sp2)–H arylation of oxazolines (17).
Scheme 9 Preparation of Pd catalyst (26) for C(sp2)–H arylation of oxa-
zolines (17).
Scheme 10 Cu-Catalyzed C(sp2)–H arylation of benzotriazepinones
(29).
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In 2012, researchers from the Zelinsky Institute of Organic
Chemistry in Russia reported an atypical C-alkylation of 2-pyra-
zolines 38 with 2-(hetero)arylcyclopropane-1,1-dicarboxylates
37 in the presence of superstoichiometric gallium trichlo-
ride.33 A C,N-bis-alkylation product 39 was obtained as a major
compound in refluxing dichloromethane (Scheme 12).
However, performing this reaction at room temperature led to
a greater proportion of byproducts (40 and 41). Interestingly,
other Lewis acids, such as scandium and ytterbium triflates,
predominantly resulted in the formation of cycloaddition
product 41.34 This cycloadduct 41 is generated via an inter-
action of the N(2)-atom in 2-pyrazoline 38 with the electrophi-
lic center of cyclopropane 37 after initial activation with a
Lewis acid (Scheme 13). In contrast, activation of both reac-
tants (37 and 38) seems to occur at higher temperature, which
redistributes the electron density within the pyrazoline ring.
This enhances the nucleophilicity at the C(3)-atom and results
in the formation of 1-pyrazoline C(3)-adduct 42. Subsequent
tautomerization via migration of the hydrogen from C(3)- to
N(1)-position, followed by interaction with another equivalent
of cyclopropane (37) generates the bis-alkylation product 39.
While analyzing the data of various studies focused on the
C(sp2)–H functionalization of cyclic azomethines, the tendency
to apply compounds of the aldonitrone family (featuring an
additional N-oxide on the azomethine) as C–H substrates for
these transformations became apparent.35 They are easily
accessible via a multitude of procedures (e.g., oxidation reac-
tions (Scheme 14a), condensation reactions of
N-monosubstituted hydroxylamines (Scheme 14b), or reactions
of oximes with electrophiles (Scheme 14c)).35 The N-oxide
group of nitrones has been exploited by various research
Scheme 11 Pd-Catalyzed direct arylation and olefination of 4,4-
dialkyl-1H-imidazol-5(4H)-ones (32).
Scheme 12 GaCl3-mediated coupling of 5-substituted 2-pyrazolines
(38) with 2-arylcyclopropane-1,1-dicarboxylates (37).
Scheme 13 Proposed mechanism for a GaCl3-mediated coupling of
5-substituted 2-pyrazolines (38) with 2-arylcyclopropane-1,1-dicarboxy-
lates (37).
Scheme 14 General routes towards nitrones.35
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groups as an elegant directing group for C(sp2)–H functionali-
zation of azomethines.6c In particular, significant attention
has been paid to imidazolone N-oxides.
In 2010, the Merck Research Laboratory in the USA achieved
the synthesis of 2-alkenylimidazolones (45) via a 1,3-dipolar
cycloaddition (1,3-DC) of alkenes (44) to cyclic nitrones (43,
Scheme 15).36 The procedure involves a one-pot three-step
process (Scheme 16). Initially, the cycloadduct (46) is formed
from imidazolone N-oxide (43) and alkene (44) in refluxing
ethanol. After cooling to ambient temperature, subsequent
treatment with aqueous NaOH (1 N) (base-induced N–O bond
cleavage) and HCl (1 N) (acid-induced water elimination) deli-
vered the target compound 45 in good to excellent yields.
Various aromatic and aliphatic alkenes 44 were compatible
with the developed reaction conditions.
Two years later, researchers from Albany Molecular
Research Inc. reported the first Pd-catalyzed arylation of aldo-
nitrones 47 with aryl bromides (18, Scheme 17).37 The reaction
conditions were similar to those previously reported by Fagnou
for the arylation of heteroaromatic N-oxides.38 A cross-coupling
between 47 and phenyl bromide (18a) successfully delivered
48a; however, only a moderate yield of 49% was obtained
(Scheme 17a). A significant improvement in yield was achieved
via protection of the imidazolone moiety with either the tert-
butoxycarbonyl (Boc) or 2,4-dimethoxybenzyl (DMB) protecting
group (48b–c). With the optimal DMB protecting group in
hand, the authors were able to arylate aldonitrone 47a with
various aryl bromides (18) in good to excellent yields
(Scheme 17b). This approach was also successfully applied for
the synthesis of GSK2137305 56 (Scheme 18), a known selec-
tive inhibitor of glycine transporter type 1 (GlyT1), exhibiting
effectiveness for neurological and neuropsychiatric dis-
orders.39 The procedure nicely illustrates the N-oxide directing
group, which can be easily introduced via oxidation of cyclic
amine 53 with m-CPBA (vide supra) and removed by employing
PBr3, yielding cyclic azomethine target compound 56. Other
reagents to cleave N-oxides are also available (e.g., CuI/Zn
system, PnBu3, Mo(CO)6, InCl3, etc.).
35
In 2011, the synthesis of novel pseudouridine-like com-
pounds (e.g., 62), bearing 1-pyrroline-1-oxide moieties instead
of sugar residues, was reported by Koszytkowska-Stawińska
(Scheme 19).40 Pseudouridine (ψ-uridine) is a natural
C-nucleoside found in various types of RNA. This compound is
supposed to play a key role in fine-tuning the functions of
RNA, and it contributes likely to the preservation of the RNA
structure during translation.41 Moreover, ψ-uridine is also
active against ionizing radiation and chemical mutagens.42
These protective effects are associated with the ability of the
nucleoside to trap free radicals formed by mutagens. The
derivatives of 1-pyrroline 1-oxide are efficient spin-traps for
EPR analysis (the most prominent example is 5,5-dimethyl-1-
pyrroline N-oxide, DMPO).43 Many azaheterocycles, which are
structurally similar to the pyrroline scaffold (pyrrolidines, oxa-
zoles, isoxazoles, etc.), are able to mimic a furanose residue.
The replacement of the ribose residue in pseudonucleosides
with a 5,5-bis(hydroxymethyl)-1-pyrroline-1-oxide was therefore
envisioned to improve the antimutagenic activity. To obtain
such modified ψ-uridines, the authors first synthesized O,O′-
cyclohexylidene protected 5,5-bis(hydroxymethyl)-1-pyrroline
1-oxide (58) as an aldonitrone precursor. Subsequent addition
of either C(5)-lithiated 2,4-dimethoxypyrimidine (57-Li,
Scheme 19a) or the analogous Grignard reactant (57-MgBr,
Scheme 19b), followed by copper-catalyzed aerobic oxidation
of the adduct and acetal deprotection of the resulting nitrone
59 with NaOAc in AcOH (Scheme 19c), afforded the desired
pseudouridine aza-analogues 62. The coupling with the
Scheme 15 Formal C(sp2)–H alkenylation of imidazolones (43) via the
N-oxide.
Scheme 16 A proposed mechanism for alkenylated imidazolone (45)
synthesis from the corresponding imidazolone N-oxide (43).
Scheme 17 (a) Effects of the N-substituent in lactam 47 on the direct
arylation reaction yield; (b) Pd-catalyzed coupling of 4-DMB-protected
imidazol-3-one 1-oxide (47a) with aryl bromides (18).
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lithium derivative (57-Li) was less successful, as nitrone dimer-
ization was observed as the major process, probably due to
deprotonation at the C(2)–H of 1-pyrroline 1-oxide (58).
In 2012, Chavant & Blandin et al. reported an efficient
approach for Pd- or Pd/Cu-catalyzed direct arylation of cyclic
aldonitrones (63–65),44 which is related to the C–C coupling of
Scheme 18 The synthesis of GSK2137305 (56).
Scheme 19 Synthesis of pseudouridine aza-analogue 62.
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imidazolone N-oxides (47) with aryl bromides (18) reported by
the AMRI research group (Scheme 17). The cyclic aldonitrone
2-isopropyl-1,2-dimethyl-5-oxo-2,5-dihydro-1H-imidazole
3-oxide (63, MiPNO, Fig. 2) is a versatile precursor for the syn-
thesis of α-amino acids (via 1,3-dipolar cycloaddition reactions
with alkenes followed by cleavage of the N–O bond)45 and was
one of the key studied substrates. Pivalic acid (20 mol%) was
an essential additive for a successful cross-coupling with aryl
bromides (18), enhancing the yield dramatically (Scheme 20a).
Alternatively, CuBr·DMS (5 mol%) with 1,10-phenanthroline
(Phen, 5 mol%) as a ligand proved also to be an effective addi-
tive to achieve quantitative conversion of 63. It is worth noting
that no synergistic effect was observed, when these two addi-
tives (PivOH and CuBr·DMS) were used simultaneously.
Interestingly, in the absence of the palladium catalyst, a cata-
lytic amount of CuBr·DMS enabled the conversion of aldoni-
trone 63 into the corresponding homocoupling product (i.e. a
nitrone 2,2′-dimer without one of two N-oxide functions).
Employing dibromo(hetero)arenes (69) with two equivalents of
aldonitrone (S)-63 afforded successfully bis-nitronyl products
70 in good yields (Scheme 20b). The reaction is not specific to
MiPNO (63), since a range of other heterocyclic non-aromatic
aldonitrones can be employed in this cross-coupling reaction,
as illustrated for DMPO (64, Scheme 21a) and 3,3-dimethyl-3,4-
dihydroisoquinoline 2-oxide (65, Scheme 21b). The reaction
with DMPO is interesting due to the presence of potentially
labile allylic H-atoms relative to the imine double bond
(Scheme 21a). In contrast, acyclic nitrones, such as N-tert-
butyl-α-phenylnitrone (66, PBN) or glyoxylic nitrone (67), were
not compatible with this kind of arylation (Fig. 2). It has been
suggested that these cross-coupling processes are likely to
proceed via the so-called concerted metalation–deprotonation
(CMD) mechanism,46 explaining the beneficial effect of PivOH,
described previously for Pd-catalyzed direct arylations of
(hetero)aromatic substrates (i.e. for azine N-oxides). It is worth
noting that this method has been used for the synthesis of
chiral imidazolidin-4-one nitroxides starting from enantiopure
63, and they are regarded as potentially active catalysts for
aerobic oxidation of alcohols.47 In particular, catalytic appli-
cation of such compounds in enantiopure form allows one to
achieve atroposelective desymmetrization during a diol oxi-
dation process.47
Special attention has recently been paid to C–H functionali-
zation of related non-aromatic 2H-imidazole 1-oxides (7) fea-
turing an extra unsaturation. In 2012, our research group
reported the first successful cross-coupling reactions of 2,2-
dialkylated 4-phenyl-2H-imidazole 1-oxide (7b) with 1,2,4-tri-
azine 73 (Scheme 22) or its N-oxide 77 (Scheme 23).48 The reac-
tion mechanism includes the initial lithiation of the azo-
methine C–H bond in aldonitrone 7b, which is assisted by the
N-oxide (Directed ‘ortho’ Metalation (DoM)49), followed by reac-
tion with 1,2,4-triazine 73 or its N-oxide 77 to afford NLi- or
OLi-adducts (74 or 78). These adducts are subsequently proto-
nated with water into the corresponding NH- or OH-intermedi-
ates (75 or 79). Finally, rearomatization of the dihydrotriazine
ring in 75/79 occurs either through spontaneous elimination
of water, affording the coupling product without the N-oxide
function (76/80), or by oxidation with 2,3-dichloro-5,6-dicyano-
1,4-benzoquinone (DDQ) to give the corresponding N-oxide 81
(Scheme 23). It is worth noting that cleavage of the N-oxide
moiety in the triazine fragment of 77 occurs via the ‘Addition–
Elimination (AE)’ protocol, while the N-oxide moiety remains
untouched via the ‘Addition–Oxidation (AO)’ protocol.
Our group also reported the coupling of 2H-imidazole
1-oxide 7b with 1,10-phenanthroline (82a), quinoxaline (82b),
Fig. 2 Cyclic and acyclic nitrones studied: MiPNO (63); DMPO (64);
3,3-dimethyl-3,4-dihydroisoquinoline 2-oxide (65); PBN (66); glyoxylic
nitrone (67).
Scheme 20 Pd- and Pd-/Cu-Catalyzed direct arylations of MiPNO (63).
Scheme 21 Pd-Catalyzed direct arylation of DMPO (64, a) and 3,3-
dimethyl-3,4-dihydroisoquinoline 2-oxide (65, b).
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and their N-oxides (85a–b) as electron π-deficient azaheterocyc-
lic substrates (Schemes 24 and 25).50 Interestingly, the N-oxide
moiety is eliminated from the imidazole ring in the (AE)-reac-
tion of aldonitrone 7b with quinoline N-oxide 85c, whereas the
N-oxide fragment of the pyridine ring remains intact
(Scheme 25), in contrast to the reaction of nitrone 7b with tri-
azine N-oxide 77 (Scheme 23). Clearly, retention of the specific
N-oxide function in products is controlled by the stability of
the tautomeric intermediates (86a and 86b, respectively).
Scheme 22 Proposed mechanism for the coupling of 2H-imidazole
1-oxide 7b with 1,2,4-triazines (73) via DoM lithiation.
Scheme 23 Proposed mechanism for the coupling of 2H-imidazole
1-oxide 7b with 1,2,4-triazine 4-oxide 77 via DoM lithiation.
Scheme 24 Proposed mechanism for the coupling of 2H-imidazole
1-oxide 7b with azines (82) via DoM lithiation.
Scheme 25 Proposed mechanism for the coupling of 2H-imidazole
1-oxide 7b with azine N-oxides (85) via DoM lithiation.
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The same substrate 7 can be used as an electrophile rather
than as a nucleophile. Our group reported the cross-coupling
reaction of 2H-imidazole 1-oxides (7a–c) with electron-rich het-
eroarenes, such as indoles (90),24 pyrroles (92)51,52 and thio-
phenes (93) (Schemes 26–28).52 The coupling of these partners
can be done in two different ways. The first approach is
based on a PdII-catalyzed cross-dehydrogenative coupling
(Scheme 26). During the first step of the proposed catalytic
cycle (Scheme 27), organopalladium intermediate 96/97 is
formed via the reaction of Pd(OAc)2 with a heteroaromatic sub-
strate (92/93). Palladium in the intermediate 96/97 is
hypothesized to be coordinated with the oxygen atom of
nitrone 7a–c via a ligand exchange mechanism, leading to the
formation of intermediate 98/99. Subsequent carboxylate-
assisted functionalization of the nitrone C(1)–H bond takes
place (CMD-process, TS1/TS2), generating intermediate 100/
101. Finally, reductive elimination affords the target products
94/95 and Pd0. The latter is reoxidized to PdII with the super-
stoichiometric oxidant Cu(OAc)2. Interestingly, pyridine was
found to be an essential additive and presumed to play a role
of ligand (Ln) stabilizing organometallic intermediates.
The second approach is a cine-type reaction based on the
SN
H(AE) process between 2,2-dialkylated 4-phenyl-2H-imid-
azole 1-oxides (7a–c) and indoles or pyrroles (90 or 92) as coup-
ling partners (Scheme 28). For these transformations, the acy-
lating reagent plays a crucial role, since it reacts with the
N-oxide moiety of 7a–c to generate a more electrophilic species
104 and immediately builds in a suitable leaving group
(Scheme 29). Simple acetyl chloride can be used. These chlor-
ide salts formed then react in electrophilic addition reactions
at the C(2)-position of pyrroles (92) or the C(3)-position of
indoles (90), generating the corresponding dihydro com-
pounds (e.g., 105). Subsequent spontaneous elimination of
acetic acid affords the hydrochloride salts of the desired pro-
ducts 102/103. Notably and in line with the substitution
pattern, this method is not compatible with pyrroles (92) and
indoles (90) bearing electron-withdrawing groups, i.e. nitro or
acetyl groups.
The nucleophile can also be an organometallic reactant
(Scheme 30). A challenging example is ortho-carboranyllithium
Scheme 27 Proposed catalytic cycle for the oxidative coupling of 2H-
imidazole 1-oxides (7a–c) with pyrroles (92) or thiophenes (93).
Scheme 26 PdII-Catalyzed oxidative coupling of 2H-imidazole
1-oxides (7a–c) with indoles (90, a), pyrroles (92), and thiophenes (93,
b).
Scheme 28 The SN
H reaction of 2H-imidazole 1-oxides 7a–c with
indoles (90, a) and pyrroles (92, b).
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(106). The reaction with 2H-imidazole 1-oxides was reported in
2018.53 The nucleophile is particularly interesting, as organo-
boron compounds and their heterocyclic derivatives are poten-
tial agents for boron neutron capture therapy (BNCT) of
cancer.53 Given the nucleophilicity of organolithium species,
N-oxide activation is in this case not required; in fact, it could
competitively react at the carbonyl of the ester introduced, and
a reaction with acetyl chloride is merely used as a quencher to
rearomatize. Besides eliminative SN
H(AE), an oxidative SN
H(AO)
strategy keeping the N-oxide in the structure is possible
(Scheme 30). Very recently, the analogous protocol has also
been applied for the direct C(sp2)–H arylation of 2H-imidazole
1-oxides 7 with another organometallic reactant, pentafluoro-
phenyllithium 110 (Scheme 31).54 Some of the resulting coup-
ling products 112/113 are considered as promising push–pull
fluorophores to be useful in the design of novel fluorometric
sensors.
3. Conclusions and outlook
A systematic overview of C(sp2)–H functionalization reactions
for the modification of cyclic azomethine-based compounds
has been performed. As functionalizing reactants, both
carbon-centered nucleophiles and electrophiles can be used
(furthermore, the options for employing heteroatom-centered
synthons gradually appear to become accessible as well,55
although this area is still in its infancy). Meanwhile, the use of
cyclic aldonitrones as starting azomethine substrates turned
out to be prevalent over other related compounds, such as
imines or hydrazones. Undoubtedly, this is due to the remark-
able properties of the nitrone N-oxide moiety, which can both
act as a directing group and as a leaving group.
Although aldonitrones are shown to react readily with a
number of electrophilic and nucleophilic synthons, it seems to
be rather odd that the examples of radical C(sp2)–H
functionalization of these compounds are scarcely known at
the moment.35 After all, nitrones have become widely appli-
cable exactly due to their radical addition reactions affording
relatively stable paramagnetic nitroxides useful for EPR ana-
lysis. In this connection, we believe that stepping into the
above-mentioned terra incognita can be a milestone for the
further development of the discussed topic.
Another certainly considerable objective is the sustainabil-
ity of the process. Though very effective synthetic method-
ologies have been developed in the past decade, there is still
quite a lot to be improved in terms of greenness and compli-
ance with the PASE principles. Several approaches surveyed in
Scheme 29 Proposed reaction mechanism for the SN
H reaction of 2H-
imidazole 1-oxides (7a–c) with pyrroles (92) (cine reaction).
Scheme 30 SN
H reactions of 2H-imidazole 1-oxides (7) with ortho-car-
boranyllithium (106) via SN
H(AE) and oxidative SN
H(AO) strategies.
Scheme 31 SN
H reactions of 2H-imidazole 1-oxides (7) with pen-
tafluorophenyllithium (110) via SN
H(AE) and oxidative SN
H(AO) strategies.
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this overview deal with transition metal catalysis. Although cat-
alysis is inherently a green methodology, an aryl bromide or
iodide reactant partner, as well as noble metals (sometimes
with complex ligands), is typically required. Besides, it often
appears to be necessary to use (super)stoichiometric quantities
of additives (e.g., bases). Indeed, these reactions are highly
valuable for modern organic synthesis and open new horizons
compared, for instance, with the conventional ‘electrophile–
nucleophile’ interactions, yet there still remains room for
further improvement. For example, the use of base metals as
catalysts or cross-dehydrogenative procedures, which are inher-
ently more interesting, considering no prefunctionalization of
the reactant is required (though this can pose regioselectivity
issues in return). However, if no sustainable oxidant is used,
nothing can be gained by employing a cross-dehydrogenative
approach, as it is still not suitable for scaling, albeit very
useful for discovery research purposes. Oxygen,26a hydrogen
peroxide,26b and electric current56 are interesting oxidants.
Photoredox-catalyzed57 and organocatalyzed58 C–H functiona-
lizations certainly also hold promise with respect to green
chemistry. To the best of our knowledge, they have not yet
been applied for C(sp2)–H bond functionalization in cyclic azo-
methines and aldonitrones. Thus, investigations aimed at
further improving the sustainability of the current processes
are expected to be the focus of research in the next few years.
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